semaglutide subcutaneous Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating 7.2 mg for obesity Ozempic | American Diabetes Association

Other recognised side effects include injection site reactions, fatigue, dizziness, headache, and increased resting heart rate (common)

There should be a generic form of liraglutide released in the UK later this year.

Routes of Administration Subcutaneous injection is the only route for injectable semaglutide

Stabilized and controlled blood sugar levels can also help improve other areas of overall health

Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)

With enough patience, strong support from others, and help from your doctor, you can make progress